Clinical trial administration

GPT4DFCI

biodata — Wed, 27 Mar 2024 23:49:12 +0000

GPT4DFCI

biodata Wed, 03/27/2024 - 19:49

GPT4DFCI, a private, secure, HIPAA-compliant generative AI tool based on GPT and o1 models, is now available to Dana-Farber workforce members to try out for work purposes, excluding clinical care.

To request access:

If working remotely, be sure you're connected to VPN.
Visit the Informatics & Analytics GPT4DFCI sign-up page.
Log in with your MGB username and password.
Complete and submit the ticket.
Once your access is granted, visit https://gpt4dfci.dfci.harvard.edu

Please review Dana-Farber’s new policy on acceptable use of generative AI. Workforce members are required to use generative AI systems in a manner that maintains the protection of protected health information (PHI), personally identifiable information (PII), and other confidential information. It also must be used in a manner that maintains the integrity required for scientific analysis as well as generation of scientific content such as text, images, graphics, and figures.

Please remember, publicly available AI tools can pose significant privacy and security risks. For this reason, only Dana-Farber-approved AI tools can be used for work purposes.

Do you want to discuss an idea for a custom GPT? Would you like API access? Get in touch.

More information: GPT4DFCI Press Release.

Analytics users

Basic researchers

Belfer Office for Dana-Farber Innovations (BODFI)

Budget office

Clinical researchers

Clinical trial administration

Office of General Council

Pharmacy

Research administrators

Research staff

Technical Support

REDCap

rio — Mon, 04 Mar 2024 20:18:49 +0000

REDCap

DF/HCC

DFCI

rio Mon, 03/04/2024 - 15:18

REDCap provides a secure web application for building and managing online surveys and databases.

REDCap (Research Electronic Data Capture) is a secure, HIPAA-compliant web-based application designed for data collection for research studies. It enables rapid project development and provides users with advanced functionality, complete autonomy and control of projects, and direct exports to common statistical packages.

COMING: